Skip to main content

UBS Group AG

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in MLYS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,755,858
+$7,100,254 QoQ
Shares Held
361,596
+268.9% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 226 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLYS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. MLYS ranks #116 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MLYS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,755,858 361,596
2026-03-31 $2,655,604 98,029
2025-12-31 $7,304,449 201,280
2025-09-30 $3,393,990 89,504
2025-06-30 $1,557,830 115,139
2025-03-31 $590,116 37,161
2024-12-31 $601,774 48,885
2024-09-30 $194,969 16,100
2024-06-30 $126,207 10,787
2024-03-31 $254,572 19,719
2023-12-31 $185,760 21,600
2023-09-30 $71,333 7,501
2023-06-30 $136,502 8,006